The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis
S Richards-Taylor, SM Ewings, E Jaynes… - Journal of clinical …, 2016 - jcp.bmj.com
Introduction Gastroenteropancreatic neuroendocrine tumours (GEP NETs) are classified
according to tumour mitotic count or Ki-67 labelling index (LI). Aim (s) To systematically …
according to tumour mitotic count or Ki-67 labelling index (LI). Aim (s) To systematically …
Prolactinomas
ME Molitch - Prolactin, 2001 - Springer
Prolactinomas are the most common of the hormone-secreting tumors of the pituitary. There
are many causes of hyperprolactinemia which must be excluded and an imaging procedure …
are many causes of hyperprolactinemia which must be excluded and an imaging procedure …
[HTML][HTML] Gonadotroph tumors show subtype differences that might have implications for therapy
MD Ilie, A Vasiljevic, C Louvet, E Jouanneau… - Cancers, 2020 - mdpi.com
Gonadotroph tumors, although frequent, are poorly studied and understood, being usually
included in the larger nonfunctioning pituitary neuroendocrine tumors (PitNETs) group …
included in the larger nonfunctioning pituitary neuroendocrine tumors (PitNETs) group …
Prognostic factors in gastrointestinal endocrine tumors
G Rindi, T D'Adda, E Froio, G Fellegara, C Bordi - Endocrine pathology, 2007 - Springer
The gastrointestinal endocrine tumors are neoplastic lesions with often elusive malignant
clinical behavior. The current WHO classification attempted to define a more effective …
clinical behavior. The current WHO classification attempted to define a more effective …
Cell biology, clinicopathological profile, and classification of gastro-enteropancreatic endocrine tumors
Recent developments in the field of endocrine cell biology and pathology at both
morphological and molecular levels are briefly outlined and discussed as a basis for …
morphological and molecular levels are briefly outlined and discussed as a basis for …
[HTML][HTML] Histopathological classification of non-functioning pituitary neuroendocrine tumors
E Manojlovic-Gacic, BE Engström, O Casar-Borota - Pituitary, 2018 - Springer
Non-functioning pituitary neuroendocrine tumors do not cause endocrine symptoms related
to hypersecretion of adenohypophyseal hormones and are clinically characterized by …
to hypersecretion of adenohypophyseal hormones and are clinically characterized by …
Genes differentially expressed in prolactinomas responsive and resistant to dopamine agonists
VQ Passos, MAHZ Fortes, D Giannella-Neto… - …, 2009 - karger.com
Abstract Background/Aims: Prolactin (PRL) secretion and its gene expression are inhibited
by dopamine. Prolactinomas are the most common secreting pituitary adenomas, and …
by dopamine. Prolactinomas are the most common secreting pituitary adenomas, and …
Growth potential of female prolactinomas
H Nishioka, H Ito, J Haraoka, A Hirano - Surgical neurology, 2001 - Elsevier
BACKGROUND The indications for treatment in female patients with small prolactinomas
and mild or no symptoms are controversial. The aim of this study was to investigate whether …
and mild or no symptoms are controversial. The aim of this study was to investigate whether …
Tumour biology and histopathology of neuroendocrine tumours
G Klöppel - Best practice & research Clinical endocrinology & …, 2007 - Elsevier
The tumours of the disseminated/diffuse neuroendocrine cell system are a group of
neoplasms sharing uniformly appearing cells which differ from each other in their biology …
neoplasms sharing uniformly appearing cells which differ from each other in their biology …
Clinical management of prolactinomas
J Webster - Best Practice & Research Clinical Endocrinology & …, 1999 - Elsevier
Prolactinomas are benign, sporadic pituitary tumours that typically present with
amenorrhoea and galactorrhoea in women, and hypogonadism and space-occupying …
amenorrhoea and galactorrhoea in women, and hypogonadism and space-occupying …